Abstract Parkinson's disease (PD) patients have excessive iron depositions in substantia nigra (SN). Neuroinflammation characterized by microglial activation is pivotal for dopaminergic neurodegeneration in PD. However, the role and mechanism of microglial activation in iron-induced dopaminergic neurodegeneration in SN remain unclear yet. This study aimed to investigate the role and mechanism of microglial β-nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) activation in iron-induced selective and progressive dopaminergic neurodegeneration. Multiple primary midbrain cultures from rat, NOX2 +/+ and NOX2 −/− mice were used. ) and intracellular reactive oxygen species (iROS) were determined by measuring SODinhibitable reduction of tetrazolium salt WST-1 and DCFH-DA assay. mRNA and protein were detected by real-time PCR and Western blot. Iron induces selective and progressive dopaminergic neurotoxicity in rat neuron-microglia-astroglia cultures and microglial activation potentiates the neurotoxicity. Activated microglia produce a magnitude of O 2 ·− and iROS, and display morphological alteration. NOX2 inhibitor diphenylene iodonium protects against iron-elicited dopaminergic neurotoxicity through decreasing microglial O 2 ·− generation, and NOX2 −/− mice are resistant to the neurotoxicity by reducing microglial O 2 ·− production, indicating that ironelicited dopaminergic neurotoxicity is dependent of NOX2, a O 2 ·− -generating enzyme. NOX2 activation is indicated by the increased mRNA and protein levels of subunits P47 and gp91. Molecules relevant to NOX2 activation include PKC-σ, P38, ERK1/2, JNK, and NF-КB P65 as their mRNA and protein levels are enhanced by NOX2 activation. Iron causes selective and progressive dopaminergic neurodegeneration, and microglial NOX2 activation potentiates the neurotoxicity. PKC-σ, P38, ERK1/2, JNK, and NF-КB P65 are the potential molecules relevant to microglial NOX2 activation.
Introduction
Parkinson's disease (PD) is a common neurodegenerative disease, generally affecting population over 55 years old. Mechanisms for the accelerated loss of dopaminergic neurons in substantia nigra pars compacta (SNpc) remain enigmatic. Neuroinflammation featured by microglial activation is demonstrated by a wealth of evidence as an engine driving progressive dopaminergic neurodegeneration [1] . Microglia are the resident immune cells in the brain. Under physical condition, microglia play protective role on the brain through immunosurveillance and removal of cell debris. However, microglia become sensitive to disturbances in homeostasis of the brain and are readily activated during most neuropathological conditions [2] . In PD, microglia become deleterious and cause neuronal damage when they are activated by lots of exogenous factors, including 1-methyl-4-phenyl-1, 2,3, 6-tetrahydropyridine [3] , lipopolysaccharide [4] , paraquat [5] , and rotenone [6] , and endogenous factors, including neuromelanin [7] , aggregated [8] and mutant α-synuclein isoforms [9] , 6-hydroxydopamine [10] , matrix metalloproteinase-3 [11] , μ-Calpain [12] , and diesel exhaust particles [13] . Iron serves as an exogenous factor when it is uptaken excessively, and an endogenous factor when its metabolism is disturbed.
Iron is particularly pivotal in neurotransmission, myelination, and neuronal metabolism in the brain. In PD patients, an elevated iron level in substantia nigra (SN) has been documented ( [14] ). Total iron in SN is increased for 225 % in PD patients [15] . Iron level in SN may reflect a predilection to dopaminergic neurodegeneration and associated movement disorders. Furthermore, biochemical analysis indicates that iron deposition is mainly in SNpc of total SN [16] , suggesting an important role of iron deposition in PD since SNpc bears the brunt of PD pathology. Iron deposition in SNpc may be resulted from the excessive uptake [17] , abnormal metabolism [17] , iron transportation and binding-related gene mutations [18] , and compromised blood-brain barrier offering an entrance for iron from peripheral to central system [19] .
In living organisms, iron is present as either reduced Fe 2+ or oxidized Fe 3+ state. In normal subjects, the ration of Fe
in SNpc is 2:1 [20] . However, the ratio is shifted to 1:2 in PD patients [20] . Iron accumulation in PD can be contributed by the changes of a number of iron-related proteins [21] , among which, ferritin levels have been found to be decreased in postmortem PD brains [22, 23] . We also find that ferritin levels in the serum of PD patients are significantly declined comparing with control subjects (unpublished data). Ferritin, particularly, ferritin heavy chain performs the major function of converting higher toxic Fe 2+ into lower toxic Fe 3+ for the rapid absorption and utilization of iron. Accordingly, reduction of ferritin decreases its competence of converting Fe 2+ -mediated selective and progressive dopaminergic neurotoxicity using multiple well-established primary midbrain cultures [26] , and particularly explored the key role and relevant molecules of β-nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2), a superoxide (O 2 ·− )-generating enzyme, in microglial activation by using NOX2 knock out (NOX2 −/− ) mice and inhibitor.
Methods

Reagent
Materials relating cell cultures are from Invitrogen (USA). Polyclonal anti-tyrosine hydroxylase (TH), anti-complement receptors 3 (OX-42), anti-neuron-specific nuclear protein (Neu N), anti-P38, anti-extracellular signal-regulated kinase1/2 (ERK1/2), anti-c-Jun N-terminal kinase (JNK), anti-nuclear factor-КB P65 (NF-КB P65 ), and anti-protein kinase C-σ (PKC-σ) antibodies are from R&D Systems (USA). Vectastain ABC kit and biotinylated secondary antibodies are from Vector Laboratories (USA). FeCl 2 is from Alfa Aesar (UK). Fluorescence probe 2′,7′-dichlorodi-hydrofluorescein (DCFH-DA), Leu-Leu methyl ester hydrobromedia (LME), superoxide dismutase (SOD), 2-(4 lodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazo1ium (WST-1), diphenylene iodonium (DPI), and dimethyl sulfoxide (DMSO) are from Sigma-Aldrich ( USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) is from Dojindo (Japan). SYBR green PCR master mix is from Applied Biosystems (UK). Rat primary midbrain neuron-astroglia cultures were obtained by suppressing microglial proliferation with 1.5 mM LME 24 h after seeding neuron-microglia-astroglia cultures. Three days later, cultures were changed back to maintenance medium and used for treatment 7 days after seeding. The composition of the cultures included 54 % astroglia, 1 % microglia, and 45 % neurons. Immunostainings were performed 7 days after treatment [9] .
Animals
Primary Microglial Cultures
Primary microglial cultures were prepared from the whole brains of pups from 1-day-old SD rats, NOX2 
Immunostainings
Formaldehyde-fixed neuron-microglia-astroglia cultures were treated with 1 % hydrogen peroxide followed by sequential incubation with blocking solution, primary and biotinylated secondary antibodies and ABC reagents. Color was then developed and images were recorded. TH-ir dopaminergic neurons in a well, Neu N-ir total neurons and OX-42-ir microglia in nine representative areas per well were visualized under microscope at ×100 magnification (see Supplemental Material, p. 2).
Detection of Cell Viability Dopaminergic cells was seeded followed by the treatment with 5, 25, and 100 μM Fe 2+ and incubation for 24 h. MTT was then added and incubated for 6 h. Finally, DMSO was added to dissolve the formazan into a purple solution, which absorbance was quantified at wavelength of 570 nm. The formazan production was measured by the increased absorbance.
Rat primary microglial cultures were seeded for 24 h, washed two times with Hank's balanced salt solution (HBSS), received Fe 2+ treatment followed by WST-1 in HBSS with or without SOD. The absorbance at 450 nm was read for a period of 40 min. O 2 ·− production was measured by the increased absorbance in 30 min and expressed as the percentage of control group (see Supplemental Material, p. 2).
iROS Assay
Rat primary microglial cultures were seeded for 24 h, washed for two times with HBSS, received DCFH-DA, and were incubated for 2 h followed by Fe 2+ treatment. Fluorescence intensity was measured at 485 nm for excitation and 530 nm for emission. iROS production was measured by the increased absorbance in 2 h (see Supplemental Material, p. 3).
RT and Real-Time PCR Fe 2+ -induced gene expressions of microglial NOX2 subunits P47 and gp91, PKC-σ, P38, ERK1/2, JNK, and NF-КB P65 after Fe 2+ treatment were detected by RT and real-time PCR. The sequences of the forward and reverse primers were as followed: β-actin: 5′-GAGACCTTCAACACCCCAGC-3′ (F), 5′-ATGTCACGCACGATTTCCC-3′ (R); P47: 5′-ACCT GAAGCTGCCCAATGAC-3′ (F), 5′-ATGGCCCGATAGGT CTGAAG-3′ (R); gp91: 5′-GACAGATTTGCTCTGCACAA GGT-3′ (F), 5′-AGGAGAGGTTGTGTGCACCATAG-3′ (R); PKC-σ: 5′-TCCCCGCCATCCGAGCAACA-3' (F), 5′-TTGCGGCATCTCTCCGCCAG-3′ (R); P38 5′-TGGCTC GGCACACTGATGAC-3' (F), 5′-CCGGTCAACAGCTC AGCCAT-3′ (R); ERK 1/2: 5′-GACCCTGAGCACGACC ACAC-3′ (F), 5′-ATAGGCCGGTTGGAGAGCAT-3′ (R); JNK: 5′-CCCACCACCAAAGATCCCTG-3′ (F), 5′-TGAC AGACGGCGAAGACGAC-3′ (R); NF-КB P65 : 5′-GCCG GCCTCGGGACAAACAG-3′ (F), 5′-TCGCCAGAGGCG GAAATGCG-3′ (R). Total RNA was isolated with Trizol reagent, followed by purification, reversed transcription with MuLV reverse transcriptase and oligo-dT primers and realtime PCR analysis using SYBR green PCR master mix. The relative differences in expressions between groups were determined using cycle time (Ct) values as follows: the Ct values for the genes of interest were first normalized with β-actin of the same sample, then the relative differences between control and Fe
2+
-treated groups were calculated and expressed as relative increases, setting control as 100 %. Assuming that the Ct value was reflective of the initial starting copy and that there was 100 % efficiency, a difference of one cycle was equivalent to a twofold difference in starting copy. Standard curve analysis was performed and used for the calculation. . One, 4, and 7 day (s) after treatment, the number of dopaminergic neurons was visualized after TH staining. Results are expressed as a percentage of the vehicle-treated control group and are the mean ± SE from three independent experiments in triplicate (a). *P < 0.05 and **P <0.01 for Fe 2+ -treated groups vs. vehicle-treated control group. Representative microscopic images are shown for TH-ir dopaminergic neurons (TH staining, ×100 magnification). Scale bar = 100 μm (b). Rat primary midbrain neuron-microglia-astroglia cultures were seeded in a 24-well plate at 5×10 . Seven days later, the numbers of dopaminergic neurons and total neurons were visualized after TH and Neu N staining, respectively. Results are expressed as a percentage of the vehicle-treated control group and are the mean ± SE from three independent experiments in triplicate (c). *P <0.05 for TH-ir dopaminergic neurons vs. Neu N-ir total neurons Western Blot Primary microglial cultures treated with Fe 2+ were detached by scraping in sampling buffer. NOX2 subunits P47 and gp91, PKC-σ, P38, ERK1/2, JNK, and NF-КB P65 were isolated via acid extraction adjusted to equal protein concentrations and separated by 4-12 % polyacrylamide-0.1 % SDS miningels, then transferred onto a PVDF membrane. Blots were incubated with primary antibody, then probed with a horseradish peroxidase-conjugated secondary antibody. Detection was performed by using ECL kit.
Statistical Analysis
Three wells were used in each treatment, which was considered as an independent experiment. Standard errors were calculated from three independent experiments. Results were expressed as the mean ± SE. Statistical significance was assessed with an analysis of one-way ANOVA, with the freedom representing the numbers of experiments minus one, followed by Bonferroni's t test using SPSS20.0 software. A value of P <0.05 was considered statistically significant.
Results
Fe
2+ Causes Progressive and Selective Dopaminergic Neurotoxicity
In rat primary midbrain neuron-microglia-astroglia cultures treated with Fe 2+ at 5, 25, and 100 μM, the number of TH-ir dopaminergic neurons is significantly reduced 1, 4, and 7 day (s) after Fe 2+ treatment, in a time-dependent manner (Fig. 1a) . Morphologically, dopaminergic neurons show smaller cell bodies, reduced cytoplasmic TH staining, and fewer and shorter dendrites 7 days after Fe 2+ treatment, in a dose-dependent manner comparing with control group (Fig. 1b) .
In rat primary midbrain neuron-microglia-astroglia cultures treated with Fe 2+ at 5, 25, and 100 μM for 7 days, Neu N-ir total neurons are largely preserved comparing with TH-ir dopaminergic neurons (Fig. 1c) -treated groups are strikingly decreased comparing with control group (Fig. 2a) . Rat primary midbrain neuron-microglia-astroglia and neuron-astroglia cultures were simultaneously treated with Fe 2+ at 5, 25, and 100 μM. Seven days later, the loss of THir dopaminergic neurons in rat primary neuron-astroglia cultures is remarkably spared comparing with midbrain neuronmicroglia-astroglia (Fig. 2b) .
Fe
2+ Elicits Progressive Microglial Activation
In rat primary microglia cultures, 25 and 100 μM Fe 2+ induces notable generation of extracellular O 2 ·− 30 min later (Fig. 3a ) and marked production of iROS 2 h later (Fig. 3b) . In rat primary midbrain neuron-microglia-astroglia cultures, numbers of OX-42-ir microglia are prominently enhanced 1, 4, and 7 day (s) after Fe 2+ treatment at 25 and 100 μM comparing with control group (Fig. 3c) . Morphologically, activated microglia are indicated by the enlarged cell bodies, irregular shape, and intensified OX-42 staining (Fig. 3d) . (Fig. 4a) and iROS 2 h later (Fig. 4b) , respectively, comparing with that derived from NOX2 −/− mice. Primary midbrain neuron-microglia-astroglia cultures derived from NOX2 +/+ and NOX2 −/− mice were treated with Fe 2+ at 25 and 100 μM. Seven days later, the number of activated microglia in NOX2 +/+ mice is evidently increased comparing with that in NOX2 −/− mice (Fig. 4c) , and the number of dopaminergic neurons in NOX2 +/+ mice is prominently decreased comparing with that in NOX2 −/− mice (Fig. 4d) (Fig. 5a, b) .
In rat primary midbrain neuron-microglia-astroglia cultures, the number of microglia is greatly enhanced and TH-ir dopaminergic neurons is highly reduced 7 days after 100 μM Fe 2+ treatment. Pretreatment with DPI at 0.01 and 0.1 μM significantly decreases the number of activated microglia (Fig. 5c ) and restores dopaminergic neuronal survival 100 μM. One, 4, and 7 day (s) after the treatment, the number of microglia was visualized and morphology was observed after OX-42 staining (c). *P <0.05 and **P <0.01 for Fe 2+ -treated groups vs. vehicle-treated control group. Representative microscopic images of microglia are shown (OX-42 staining, ×100 magnification) scale bar =100 μm (d) (Fig. 5d) ; 0.1 μM DPI alone presents no significant effect on the numbers of microglia and dopaminergic neurons (Fig. 5c, d ).
Fe
2+ Enhances Expressions of NOX2 Cytoplasm Subunit P47 and Cell Membrane Subunit gp91
In rat primary microglia cultures treated with Fe 2+ at 25 and 100 μM, mRNA levels of P47 and gp91 are observably enhanced 15 min later (Fig. 6a) and protein levels of P47 and gp91 were markedly increased 20 min later comparing with control group (Fig. 6b and c) .
Fe
2+ Elevates Expressions of PKC-δ, P38, ERK1/2, JNK, and NF-κB P65 Rat primary microglia cultures were treated with Fe 2+ at 5, 25, and 100 μM. Fe 2+ causes significant expressions of mRNA and protein of following factors at different time points: PKC-δ at 5 min (Fig. 7a, f) , mRNA of P38, ERK1/ 2, and JNK at 5 min (Fig. 7b-d) , phosphorylation of P38, ERK1/2, and JNK at 10 min (Fig. 7b-d) and NF-κB P65 at 3 h (Fig. 7e, f) . mRNA and protein levels of P38, ERK1/2, and JNK are significantly increased upon Fe 2+ stimulation at 25 and 100 μM (Fig. 7b, c, d, and g ). mRNA level of JNK is also dramatically enhanced after exposure to 5 μM Fe 2+ (Fig. 7d) .
Discussion
Iron transport and storage is a tightly regulated process, however, elevated exposure to extracellular iron in either normal condition or PD brain are reported. In normal condition, the major iron transporter protein in the body is transferrin, however, only about 30 % of all circulating transferrin units are occupied by iron [27] . Meanwhile, iron can bind to a series of small ligands with low molecular weight, such as citrate and ascorbate ions, released from astrocytes, which is called nontransferrin bound iron (NTBI). Investigator finds the presence of NTBI in the extracellular fluids [28] and the affinity of iron to small ligands is considerably smaller than that to transferrin −/− mice [29] , leading to a proportion of free iron in the extracellular space. Moreover, ferroportin, which mediates the export pathway and allows ferrous iron to be transported out of the cell [30] , has been identified in both neurons [31] and astrocytes [32] , contributing to ferrous iron in the extracellular space. Furthermore, neurons are thought to be devoid of ferritin in SNpc, in which more iron is exported instead of stored inside neurons [28] . In pathological condition of PD, it is characterized by the loss of dopaminergic neurons in SNpc with accompanying neuromelanin pigment in neuropil and pigment-laden activated macrophages [33] , suggesting that neuromelanin is released from dead dopaminergic neurons. Additionally, several studies have demonstrated the existence of extracellular Lewy bodies, the pathological hallmark of PD, and aggregates immunoreactive to α-synuclein in SNpc [2, 34] , indicating that aggregated α-synuclein is released from dead dopaminergic neurons. Interestingly, iron depositions have been found in Lewy bodies in PD brains [35] , implying that iron may be released from dead dopaminergic neurons together with aggregated α-synuclein. Iron has been shown to be toxic on dopaminergic neurons [36] , however, most of studies mainly focus on iron-induced direct neurotoxicity [37] , and less involved the role of glia, particularly microglia, the major player of neuroinflammation. Will iron in the extracellular space interact with surrounding microglia and propagate dopaminergic neurotoxicity? Here, we investigated the role and underlying mechanism of microglial activation in Fe 2+ -induced selective and progressive dopaminergic neurodegeneration.
Rat primary midbrain neuron-microglia-astroglia cultures with the composition similar to human is a well-established and useful tool for investigating the mechanism of dopaminergic neurodegeneration in PD. We firstly found that Fe induces progressive dopaminergic neurotoxicity. Neu N is a marker of all neurons. However, it is mainly used for evaluating non-dopaminergic neurons since dopaminergic neurons only account for 2-3 % of total neurons in SNpc. While Fe 2+ elicited dramatic dopaminergic neurotoxicity in rat primary midbrain neuron-microglia-astroglia cultures, we failed to see the similar neurotoxicity in Neu N-ir -elicited neurotoxicity is selective to dopaminergic neurons, supporting a close correlation between iron deposition in SNpc and PD [38] .
We then tested whether Fe
2+
-induced neurotoxicity was due to its direct effect on dopaminergic neurons or indirect effect via microglial activation. We observed that Fe 2+ slightly decreased cell viability, implying that Fe 2+ is mildly toxic to dopaminergic neurons and glia may potentiate the neurotoxicity. Which sort of glia, microglia or astroglia, is critical for Fe 2+ -potentiated neurotoxicity? Based on the finding that Fe 2+ produces severer loss of dopaminergic neurons in rat neuronmicroglia-astroglia cultures than that in neuron-astroglia cultures, we figure out a pivotal role of microglia in the enhanced neurotoxicity. Thus, microglia are promoters of Fe 2+ -induced dopaminergic neurotoxicity.
Strong evidences indicate that activated microglia secrete a myriad of neuroinflammatory factors, including ROS, nitrogen species, cytokines, prostaglandins, and chemokines, etc. [39, 40] , which causes subsequent neurotoxicity. How do microglia potentiate dopaminergic neuronal damage after Fe 2+ exposure? Here, we found that microglia produced a large amount of neurotoxic ROS, including extracellular O 2 ·− and iROS, in response to Fe 2+ exposure. Extracellular O 2 ·− is the earliest factor produced after activation of NOX2, the key O 2 ·− -producing enzyme in brain microglia [41] . One of the potential mechanisms mediating toxic effect of O 2 ·− is through forming strong toxic intermediate like peroxinitrite by NO [42] . O 2 ·− released from microglia displays autocrine effect to further enhance the expression of neuroinflammatory factors, including TNF-α [43] and PGE 2 [8] through formation of hydrogen peroxide [44, 45] . Thus, early O 2 ·− generation by activated NOX2 is critical in Fe 2+ -mediated dopaminergic neurotoxicity. iROS serves as the second messenger in neuroinflammatory event [26] . Among the multiple sources of iROS, NOX2-generating O 2 ·− contributes more than 60 % of total iROS [46] . iROS triggers NF-КB expression and produces downstream neuroinflammatory factors. The production of each neuroinflammatory factor may not be sufficient, however, neuroinflammatory factors may work together and amplify the toxic effect of each other, potentiating dopaminergic neurotoxicity (data not shown). Thus, iROS greatly contributes to Fe 2+ -provoked dopaminergic neurotoxicity. Morphologically, Fe 2+ causes continuous microglial activation demonstrated by the increased number of microglia with time extending, enlarged cell bodies, irregular cell shape, and intensified OX-42 staining. Accordingly, we conclude that microglial activation serves as an engine driving dopaminergic neurodegeneration and runs through the whole degenerative process.
NOX family is composed of NOX1-5 and dual oxidase 1-2 [41] . NOX2 is mainly distributed in SN, striatum, hippocampus, and cortex [47] . In these regions, scavenger receptor and macrophage antigen-1 receptor that can identify and remove external subjects are mainly expressed in microglia but not in astroglia and neurons. Upon varies of stimuli, O 2 ·− generated by NOX2 in microglia are far more than that in astroglia and neurons, for example, in LPS in vitro model, it is NOX2 activation in microglia but not in astroglia and neurons, that elicits dopaminergic neurotoxicity; microglia derived from NOX2 +/+ mice produce more O 2 ·− and neuroinflammatory factors than that from NOX2 −/− mice [46, 48] .
Results from this investigation demonstrate that microglia are the major sources of NOX2-produced O 2 ·− after stimulation and Fe
-induced progressive and selective dopaminergic neurodegeneration is microglial NOX2-dependent. Additionally, a potential NOX2 inhibitor, DPI, is used for confirming the role of NOX2 in Fe 2+ -produced dopaminergic neurodegeneration. In addition to the finding similar to that reported by Casarejos showing that DPI decreases paraquat-elicited O 2 ·− production ( [49] ), further decline of iROS, reduction of activated microglia, and subsequent restoration of dopaminergic neurons by DPI elucidate that Fe 2+ -potentiated dopaminergic neurotoxicity is in a microglial NOX2-dependent manner.
We then investigated the potential molecular mechanism of Fe 2+ -induced NOX2 activation. In all NOX2 subunits, cytoplasm subunit P47 and the membrane subunit gp91 are pivotal for NOX2 activation [50] . In resting state, they are located in cytoplasm and membrane separately. Upon stimulation, P47 translocates to membrane and combines with gp91, during which O 2 ·− was produced. Involvement of subunits of P47 and gp91 in NOX2 activation after Fe 2+ treatment was illustrated by the strikingly Multiple signaling pathways, including PKC, MAPKs, and NF-КB are reported to be associated with neurodegeneration and neuroinflammation [51] . PKC family is greatly involved in PD, among which PKC-δ is pivotal in microlgial NOX2 activation [52] . PKC-δ increases P47 expression and causes translocation of P47 from cytoplasm to membrane [52] . Inhibition of 70 % PKC-δ expression decreases NOX2 activities for more than 90 % [53] . ROS is not only inhibited by DPI, but also by GF109203X, a PKC-δ inhibitor [54] . Hence, PKC-δ may be a potential molecule for microglial NOX2 activation. We found that PKC-δ level was significantly enhanced as early as 5 min after Fe 2+ exposure, implying that PKC-δ is an earliest biomarker relevant to microglial NOX2 activation induced by Fe 2+ . MAPKs, including P38, ERK1/2, and JNK, are activated by environmental factors and inflammagens [24, 55] , and participate in the expressions of numerous proteins highly relating to neuroinflammation, and particularly, are closely associated with NOX2 activation [56] . We found that both mRNA and protein expressions of P38, ERK1/2, and JNK were significantly increased upon Fe 2+ stimulation for 5 and 10 min respectively, which were prior to that of P47 and gp91, disclosing that MAPKs are the signaling molecules of Fe 2+ -induced microglial NOX2 activation.
NF-КB is a nuclear transcription factor mediating the production of neuroinflammatory factors [57] . NF-КB activation can be inhibited by DPI [57] , implying a potential link between NF-КB and NOX2. Additionally, NF-κB has crosstalks with MAPKs and PKC [58] . We found that NF-КB p65 level was significantly elevated 3 h after Fe 2+ treatment, thus speculate that NOX2-generated O 2 ·− after Fe 2+ treatment enters microglia and enhances iROS level, which triggers expression of NF-КB p65 and generations of neuroinflammatory factors, and propagates dopaminergic neurodegeneration.
Although mRNA and protein expressions of NOX2 subunits P47 and gp91, PKC-σ, P38, ERK1/2, JNK, and NF-kBp65 are found to be involved in NOX2 activation in this rodent in vitro model, genetics and gene expression of rodents may differ from humans. Thus, results from investigation may not be extrapolated from rodents to humans. Further study needs to be conducted regarding mRNA and protein expressions of these molecules or other relevant molecules in cerebrospinal fluid of PD patients with excessive iron depositions in SN by using magnetic resonance susceptibility weighted imaging.
In summary, we show for the first time that iron induces selective and progressive dopaminergic neurotoxicity, which is potentiated by microglia. Iron activates microglia by producing magnitude of O 2 ·− and iROS and inducing morphological alteration. NOX2 −/− mice are resistant to iron-induced neurotoxicity by reducing O 2 ·− production, and potential NOX2 inhibitor DPI protects against iron-elicited dopaminergic neurotoxicity through decreasing O 2 ·− generation, implying that iron-provoked dopaminergic neurotoxicity is microglial NOX2-dependent. NOX2 activation by iron is indicated by the increased mRNA and protein expressions of its subunits P47 and gp91. Molecules relevant to iron-induced NOX2 activation include PKC-σ, MAPKs (P38, ERK1/2, and JNK), and NF-КB P65 as their mRNA and protein expressions are all elevated. Thus, over exposure to iron may be relevant to PD. Inhibition of iron-induced neuroinflammation characterized by microglial NOX2 activation may be a novel target of drug development for PD.
